Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

This Christmas, say it with Fazer novelties

Sweets are at the heart of Finnish Christmas celebrations. The Christmas season is filled with emotions and traditions – confectionery plays an important role in creating togetherness, especially during Christmas. Sweets are also a way of showing emotions: joy, love and caring are not only expressed with words but also with actions and small gifts. The Christmas season consists of several occasions during the later part of the year: different sweets are chosen for trick-or-treating on Halloween than for the solemn Independence Day, and the treats served at Christmas parties are different from

Zaplox has been selected as the Mobile Key provider for a Proof of Concept with a leading hotel group

Zaplox has been selected as the mobile key provider for a Proof of Concept (PoC) with a leading hotel group, highlighting the increasing demand for digital self services and Zaplox’ position as a leading expert in its field.– Following the successful launch of mobile keys in Apple Wallet and Google Wallet, we are witnessing an increased interest in our solutions. This PoC reflects the growing market demand, maturity of the industry and highlights our position as a trusted provider of digital solutions, says Tess Mattisson, President & CEO of Zaplox.The PoC is a paid collaboration that

FLAGGING OF PURCHASE OF SHARES AND MAJOR CHANGE OF HOLDINGS BY PMDR IN EEVIA HEALTH PLC

Betulum AS (“Betulum”), a close associate of Martin Bjørklund, the chairman of the board of Eevia Health Plc (”Eevia” or ”The Company”), has purchased 1,000,000 shares in Eevia Health Plc.Betulum purchased 1,000,000 shares in Eevia Health Plc through the subscription of new shares in the recent Rights issue in the Company, completed in July. The Company delivered the shares to Betulum on 26 August 2024. The price for the shares Betulum subscribed for was SEK 0.60 per share, in line with the terms of the Rights issue for subscriptions in Sweden. Hence, the 1,000,000 shares were purchased for

FLAGGING OF PURCHASE OF SHARES AND MAJOR CHANGE OF HOLDINGS BY PMDR IN EEVIA HEALTH PLC

Stein Ulve, the Chief Executive Officer (CEO) of Eevia Health Plc (”Eevia” or ”The Company”), has purchased 525 800 shares in Eevia Health Plc.Stein Ulve, CEO of Eevia, has purchased 525,700 shares in Eevia Health Plc through the subscription of new shares in the recent Rights issue in the Company, which was completed in July and shares delivered in mid-August. The price for the shares Ulve subscribed for was EUR 0,05 per share according to the terms of the Rights issue for subscriptions in Finland. Hence, Stein Ulve purchased the 525,700 shares for EUR 26,285.   Stein Ulve had 2,284,

Archer Limited: Archer secures contract with TotalEnergies for a floating offshore wind project

Stavanger (August 29, 2024) Archer Wind, Archer’s floating offshore wind solutions provider, is pleased to announce the award of its first contract by TotalEnergies for delivery of the floating wind foundation for the Culzean Wind Pilot. The Culzean Wind Pilot will be connected to the Culzean platform, an offshore oil and gas facility 230 kilometres off the East coast of Scotland and will provide renewable electricity to supplement the existing power generation from gas turbines.  Installation of the project will take place in late 2025 and Archer Wind is already progressing with

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 188 – 29 AUGUST 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 171/24 and 173/24, respectively. Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Martin Badsted, Chief Financial Officer, tel.: +45 33 42 05 26, e-mail: mba@norden.com

Hempel introduces Hempaguard Ultima; the next generation of its market-leading high-performance silicone hull coating system

Hempel A/S’s new and revolutionary hull coating system, Hempaguard Ultima, delivers optimised performance and increased fuel savings, enabling vessel owners and operators to reach their decarbonisation goals.Key messages: · Hempaguard Ultima represents a revolution in hull coating systems, delivering unmatched performance including up to 21% fuel savings. · This high-performing silicone hull coating system enables vessel owners and operators to reach their decarbonisation goals, along with financial advantages, through minimal speed loss, fuel savings, and increased out-of-dock

Impero releases H1 Report 2024: Realizes DKK 35.4M in Annual Recurring Revenue corresponding to 28% growth and significantly improves cash flow from operations

Company Announcement No. 11-2024 Copenhagen, 29 August 2024 At the end of the first half of 2024, Impero realized a 28% year-on-year Annual Recurring Revenue (ARR) growth rate and delivered the best H1 ever from a contracted as well as reported ARR perspective. Revenue for H1 increased by 29%, while capacity costs (other external expenses and staff costs) in the same period increased by 14%, contributing to the planned improvement in EBITDA and lower cash-burn from operations. Impero maintains guidance for the full year of 2024 with ARR within the DKK 38M to 42M range and EBITDA

Mainstream Renewable Power and Ocean Winds project awarded its Environmental Impact Assessment for 1.1 GW floating offshore wind farm in South Korea

Mainstream Renewable Power ("Mainstream"), the pureplay global wind and solar company majority-owned by Aker Horizons ASA, announced that joint the joint venture KF Wind, a 1,125 MW floating offshore wind project being developed off the coast of Ulsan and owned by Mainstream (33.3%) and Ocean Winds (66.7 %), has secured the Environmental Impact Assessment (EIA) approval from the Ministry of Environment for the totality of the two-phase project. Award of the EIA is a key milestone for the development of the two-phase floating offshore wind project, advancing towards construction.The EIA has

Augere Medical Secures MDR CE-mark for its PolypAId™ Software and System

The MDR CE-mark is an important milestone for Augere Medical, enabling European launch of Augere’s PolypAId™ System for artificial intelligence (AI) assisted detection of polyps during colonoscopy colon cancer screening.   After more than 10 years of basic research, product and clinical development, the Medical Device Regulation (MDR) CE-mark is a crucial milestone and enables Augere Medical to start commercial launch in geographies accepting the MDR CE-mark. The basic research originated from clinical needs identified by leading Scandinavian clinicians and research organizations

Bravida Finland strengthens its position in automation in south-western Finland

Bravida Finland acquires the company Prosessiautomaatio Oy, thereby expanding its automation services in Raisio. The company has sales of around EUR 2.4 million and employs 10 people.Prosessiautomaatio Oy works with automation and provides services in system installation, system design, maintenance and remote control. The company's office is located in Raisio, near Turku.“We are very pleased to be able to welcome Prosessiautomaatio Oy’s employees to Bravida and get more automation professionals in our team. The acquisition supports Bravida's strategy and will increase the share of Bravida'

24SevenOffice Announces Launch of Strategic Partnership with Storebrand to Simplify Pension Management for Businesses

24SevenOffice is pleased to announce that it has launched a strategic partnership with Storebrand, one of the leading financial services providers in the Nordic region. This collaboration will allow 24SevenOffice to offer Storebrand’s pension solutions directly through its digital platform, further enhancing the value we provide to businesses and accounting firms.   As part of this partnership, 24SevenOffice has also been approved as a licensed ancillary insurance agent by the The Financial Supervisory Authority of Norway, enabling us to integrate Storebrand's pension products

Rejlers signs agreement with NYAB for project on Viskadalsbanan

Rejlers has signed an agreement with NYAB for an extensive infrastructure project on the Viskadalsbanan, the Borås-Varberg section. To ensure a reliable connection along the railway and improve the network's capacity, a new pipe system is now being installed to enable the installation of new fiber cables.In the Opto 2.0 railway project, the existing fibre cable, which is reaching the end of its technical life, will be replaced to ensure a stable and future-proof connection. This is of particular importance for the signalling systems along the railway. By installing a new multiduct, which

Interim Report Q2 – January – June, 2024 Redsense Medical AB (publ.)

April – June 2024 · Net sales amounted to kSEK 8,749 (4,831) · Operating profit, EBIT amounted to kSEK 613 (-3,045). · Result after tax amounted to kSEK 625 (2,966). · Earnings per share were SEK 0.04 (0.21). Significant events during the period · On April 24, The Board of Directors in Redsense resolved to carry out a directed share issue of approximately MSEK 9.8. · On May 22, Redsense announced that Discover Capital GmbH has sold all their shares in Redsense Medical AB (publ.) · On May 23, Redsense announced that ShapeQ GmbH has bought 750,000 shares

Ola Klingenborg appointed President of Coor in Sweden

Ola Klingenborg has been appointed President of Coor in Sweden, effective from the first quarter 2025, when he also joins the Executive Management Team.Ola’s most recent role was as President and CEO of the care company Team Olivia and he has a background from the media industry, working in companies like Clear Channel and Bonnier. Ola Klingenborg also has a background as a management consultant at McKinsey&Comapany. “I’m delighted that Ola has accepted the position as President of Coor in Sweden, a key role in driving the continued success of Coor. Ola is a strong leader with broad

NKT finalizes the Shetland HVDC Link supporting the transition to renewable energy of Great Britain

In close collaboration with SSEN Transmission, NKT has completed the turnkey project of connecting the Shetland Islands to the main grid in Scotland with the Shetland HVDC Link. The 320 kV HVDC interconnector is now a key contributor to the integration of renewable energy in Great Britain.Press Release29 August 2024  Interconnected power grids are essential to the green transition and with the completion of the Shetland HVDC Link 600 MW of renewable energy can now flow from the Shetland Islands to the Scottish mainland. NKT has finalized the turnkey project connecting the remote

Statement by the board of directors of Concentric in relation to the public offer from Circle BidCo

The board of directors of Concentric unanimously recommends Concentric’s shareholders to accept the public offer from Circle BidCo.   On August 29, 2024, Circle BidCo ApS (“Circle BidCo”), a wholly owned, indirect subsidiary of A.P. Møller Holding A/S, announced a public offer to the shareholders of Concentric AB (“Concentric” or the “Company”) to tender all their shares in the Company to Circle BidCo at a price of SEK 230 in cash per share (the “Offer”).   This statement regarding the Offer is made by the board of directors of Concentric pursuant to Rule II.19 of Nasdaq

BioStock: Curasight targets clinical proof-of-concept for uTREAT

Having secured financing for the ongoing clinical development of uTRACE, Curasight can now enter the next level in developing the therapeutic side of its theranostic approach. This will be done by rapidly achieving proof-of-concept in a single indication with uTREAT. BioStock contacted CEO Ulrich Krasilnikoff in conjunction with the Q2 report to learn more.Read the full article at biostock.se: https://www.biostock.se/en/2024/08/curasight-targets-clinical-proof-of-concept-for-utreat/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Investor appoints Jenny Ashman Haquinius as new Chief Financial Officer

Investor announced today that Jenny Ashman Haquinius, currently Principal at Patricia Industries, will become Chief Financial Officer (CFO) and member of the Executive Leadership Team during the fourth quarter of 2024. This follows the announcement on June 4, 2024, that the current CFO, Helena Saxon, will be leaving the company during the second quarter next year. Jenny Ashman Haquinius started at Investor in 2015 and has since contributed significantly in her roles, gaining solid knowledge of our portfolio companies, our engaged ownership model, as well as our work with new investments.

Elicera Therapeutics AB (publ) Interim Report 1 January – 30 June 2024

Second quarter (April-June 2024) · Operating profit/loss amounted to SEK -5,841,409 (-4 466 286). · Loss for the period amounted to SEK -5,622,779 (-4,335,852). · Cash flow from operating activities totalled SEK -7,733,270 (-2,146,178). · Earnings per share before and after dilution totalled SEK -0.16 (-0,22). Period (January-June 2024) · Operating profit/loss amounted to SEK -11,274,831 (-6,372,143). · Loss for the period amounted to SEK -10,992,456 (-6,602,181). · Cash flow from operating activities totalled SEK -16,997,666 (-4,181,989). · Earnings per share

Lytix Biopharma Q2 and H1 2024 results: Significant clinical advancements take Lytix Biopharma closer to commercialization

Oslo, 29 August 2024. Lytix Biopharma (“Lytix”) (Euronext Growth Oslo: LYTIX), a Norwegian immuno-oncology company dedicated to being part of tomorrow’s cancer treatment, today releases its second quarter and first half 2024 results. Lytix Biopharma is experiencing a pivotal shift for its lead drug candidates, marked by significant clinical progress.   Results from the Phase II study in patients with the skin cancer disease basal cell carcinoma (BCC) demonstrate that Lytix's lead drug candidate, LTX-315, achieved an 86% reduction in tumor size and complete elimination in over half of

Ponsse’s new solutions for sustainable harvesting on display at FinnMETKO

Ponsse will demonstrate new solutions at the FinnMETKO 2024 exhibition in Jämsä that support the daily activities of forest machine operators and help forest machine entrepreneurs monitor the profitability and productivity of their fleet. Ponsse’s new forwarders Elk and Wisend and H7 harvester heads will be showcased at the event for the first time.     In addition, we will present a material concept for fossil-free steel. Ponsse is the first forest machine manufacturer in the world which has part of its forest machine made from fossil-free steel produced by SSAB.We aim for a fossil-free

There are no items matching the current filter
There are no more items matching the current filter
Back to top